Quality of Life on the Atezolizumab/Bevacizumab Combination for Metastatic Kidney Cancer: Highlights from ASCO 2018 (BMIC-054) - 102204

Spotlight
Video

Quality of Life on the Atezolizumab/Bevacizumab Combination for Metastatic Kidney Cancer: Highlights from ASCO 2018 (BMIC-054)

BeaconMedIC has 73 videos Subscribe Here

Loading........
Description: Dr. Daniel Goldstein reviews data from ASCO 2018 on patient-reported quality of life on atezolizumab/bevacizumab compared to sunitinib in metastatic kidney cancer, along with the context of other treatment options in this setting.
Shared By : BeaconMedIC
Posted on : 08/14/18
Added : 9 months ago
Category : Kidney Cancer